Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or the "Company"), a molecular diagnostics company with a unique, patented platform ...
Global Influenza Surveillance and Response System (GISRS) network expanded by 34 new WHO-recognized National Influenza Centres (NICs) and achieved a high level of quality in virus detection across ...
HANGZHOU Ustar Biotechnology Company, a giant molecular diagnostic firm with a footprint around the world, is keen to expand ...
In 2025, Visby launched an FDA-authorized at-home STI test for women that can detect chlamydia, gonorrhea, and trichomoniasis in 30 minutes—no need to mail in samples for testing—with clinical ...
According to MarketsandMarkets™, the Lateral Flow Assays Market is projected to reach USD 13.52 billion by 2031 from USD 9.14 ...
A five-year Chinese hospital study of 5,123 women with tuberculosis shows that genital tuberculosis overwhelmingly strikes ...
The Executive Order establishes a federal initiative focused on suppressing tick and mosquito populations and addressing vector-borne disease through improved detection, screening, prevention and ...
A review argues that the world will never reach the End TB Strategy targets unless rapid, accurate testing reaches the ...
These findings were generated by the largest-ever study of "pooled" tuberculosis (TB) testing, carried out by Start4All, a ...
Co-Diagnostics, Inc. a annoncé sa participation prochaine à WHX Labs Johannesburg, qui se tiendra du 6 au 8 octobre 2026 au ...
Attendees are invited to join Co-Dx at Booth # H3.L38, where the Company will showcase the Co-Dx PCR platform and the Co-Dx™ ...
Co-Diagnostics, Inc. announced its upcoming participation at WHX Labs Johannesburg, taking place October 6-8, 2026, at the Gallagher Convention Centre in Johannesburg, South Africa. Attendees are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results